Head and Neck Squamous Carcinoma
6 clinical trials · Condition
◉ Watch Head and Neck Squamous Carcinoma
| Record | Firm | Date |
|---|---|---|
| SCT200 in Combination With SCT-I10A/Paclitaxel/Docetaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT05552807) | Sinocelltech Ltd. | 2022-06-15 |
| Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma (NCT05039606) | Guiyang Medical University | 2021-09-01 |
| Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma (NCT07147361) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2020-05-28 |
| Rituximab Plus Chemotherapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (NCT04361409) | China Medical University Hospital | 2013-05-01 |
| Trial of E10A in Head and Neck Cancer (NCT00634595) | Sun Yat-sen University | 2008-03-01 |
Track Head and Neck Squamous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.